Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

This study is currently recruiting participants. (see Contacts and Locations)

Verified February 2015 by Bayer

Sponsor:

Collaborator:

Hamilton Health Sciences Corporation, Population Health Research Institute

Information provided by (Responsible Party):

Bayer

ClinicalTrials.gov Identifier:

NCT01776424

First received: January 24, 2013

Last updated: February 5, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2018
Estimated Primary Completion Date:	January 2018 (Final data collection date for primary outcome measure)